Auron Therapeutics
Focused Team. One Purpose.
Newton, United States · $87.8M raised
- Headquarters
- Newton, Massachusetts
- Employees
- 11–50
- Business Model
- B2B
- Website
- aurontx.com
- Total Funding
- $87.8M
- Last Round
- $27.0M Series BFeb 2025
- Rounds
- 3
About
Auron Therapeutics is a patient-centered, platform-powered oncology company developing therapies that target cell-state plasticity — the root driver of cancer and inflammatory disease. Its proprietary AURIGIN platform uses AI and single-cell genomics to identify novel drug targets. Lead program AUTX-703 is in clinical development for AML and other hematologic malignancies.
Summary
Auron Therapeutics is a company based in Newton, United States. It has raised $87.8M in total across 3 rounds, most recently a $27.0M Series B round in Feb 2025. Investors include DCVC (Data Collab), Arkin Bio Ventures and Polaris Partners.
Tech & App Stack
3 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Feb 2025
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
